![Robert Gagnon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert Gagnon
Direttore Finanziario/CFO presso
OPUS GENETICS, INC.
Patrimonio netto: 3 M $ in data 31/05/2026
Profilo
Robert E.
Gagnon is Secretary, Treasurer & Director at KD Scientific, Inc. He is Independent Director at Harvard Bioscience, Inc. starting in 2025, Independent Director at Purple Biotech Ltd. since 2021, Independent Director at Bone Biologics Corp.
since 2024, and Chief Financial & Accounting Officer at Opus Genetics, Inc. starting in 2025.
Former roles include Director at Verastem, Inc. from 2022 to 2026, Chief Financial Officer, Treasurer & Executive VP at Clean Harbors, Inc. from 2012 to 2013, CAO, VP-Business Planning & Controller at Biogen, Inc. in 2012, Chief Financial Officer at Harvard Bioscience, Inc. from 2015 to 2018, Chief Financial & Business Officer at Verastem, Inc. from 2019 to 2022, Partner at Gurnet Point Capital LLC from 2022 to 2023, Chief Financial Officer at Remix Therapeutics, Inc. from 2023 to 2025, and Manager-Global Orthobiologics R&D at Zimmer Biomet, Inc. from 2013 to 2017.
Education includes undergraduate studies at Bentley University and an MBA from MIT Sloan School of Management.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
OPUS GENETICS, INC. 0,73% | 23/04/2026 | 592.158 ( 0,73% ) | 3 M $ | 31/05/2026 |
VERASTEM, INC. 0,07% | 24/03/2026 | 41.678 ( 0,07% ) | 180 466 $ | 31/05/2026 |
| 09/06/2026 | 11.000 ( 0,24% ) | 64 680 $ | 31/05/2026 | |
PURPLE BIOTECH LTD. 0,15% | 18/03/2026 | 3.062.500 ( 0,15% ) | 10 933 $ | 31/05/2026 |
BONE BIOLOGICS CORP. -.--% | 23/02/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Posizioni attive di Robert Gagnon
| Società | Posizione | Inizio |
|---|---|---|
| PURPLE BIOTECH LTD | Direttore/Membro del Consiglio | 03/03/2021 |
| BONE BIOLOGICS CORPORATION | Direttore/Membro del Consiglio | 08/01/2024 |
| HARVARD BIOSCIENCE, INC. | Direttore/Membro del Consiglio | 16/07/2025 |
| OPUS GENETICS, INC. | Direttore Finanziario/CFO | 02/09/2025 |
KD Scientific, Inc.
 KD Scientific, Inc. Medical SpecialtiesHealth Technology Develops and manufactures syringe pumps used by research laboratory markets globally | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Robert Gagnon
| Società | Posizione | Fine |
|---|---|---|
| VERASTEM, INC. | Direttore/Membro del Consiglio | 21/05/2026 |
Remix Therapeutics, Inc.
 Remix Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Direttore Finanziario/CFO | 30/06/2025 |
Gurnet Point Capital LLC
 Gurnet Point Capital LLC Investment ManagersFinance Gurnet Point Capital invests in companies located in the United States. The firm targets companies operating in the fields of life sciences and medical technologies sector. It provides financing for buyout stage capital requirements. It also acquires majority stake and control positions. | Corporate Officer/Principal | 01/06/2023 |
| VERASTEM, INC. | Direttore Finanziario/CFO | 31/10/2022 |
| ░░░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Robert Gagnon
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
55
Relazioni di 1° grado
13
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 13 |
|---|---|
Clean Harbors, Inc.
 Clean Harbors, Inc. Environmental ServicesIndustrial Services Provides environmental and industrial waste recycling services | Industrial Services |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Harvard Bioscience, Inc.
 Harvard Bioscience, Inc. Medical SpecialtiesHealth Technology Manufactures, develops and markets apparatus and scientific instruments | Health Technology |
KD Scientific, Inc.
KD Scientific, Inc. Medical SpecialtiesHealth Technology Develops and manufactures syringe pumps used by research laboratory markets globally | Health Technology |
Bentley University
 Bentley University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Verastem, Inc.
 Verastem, Inc. BiotechnologyHealth Technology Discovers and develops drugs | Health Technology |
Purple Biotech Ltd.
 Purple Biotech Ltd. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical drug discovery and development services | Health Technology |
MIT Sloan School of Management
 MIT Sloan School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bone Biologics Corp.
 Bone Biologics Corp. Medical SpecialtiesHealth Technology Develops ortho biologic products | Health Technology |
Gurnet Point Capital LLC
Gurnet Point Capital LLC Investment ManagersFinance Gurnet Point Capital invests in companies located in the United States. The firm targets companies operating in the fields of life sciences and medical technologies sector. It provides financing for buyout stage capital requirements. It also acquires majority stake and control positions. | Finance |
Remix Therapeutics, Inc.
Remix Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Ocuphire Pharma, Inc.
 Ocuphire Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceuticals for eye disorders | Health Technology |
Zimmer Biomet, Inc. |
